Turhan Caskurlu

Turhan Caskurlu

Auto-generated profile, based on publicly available information

Turhan Caskurlu

Department of Urology, Istanbul Medeniyet University School of Medicine, İstanbul, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2021 in International Neurourology Journal
Verified
Journal Article
Open access
PDF file
YDYavuz Onur Danacioglu
Yavuz Onur Danacioglu
BEBulent Erol
Bulent Erol
SOSeyma Ozkanli
Seyma Ozkanli
AYAsif Yildirim
Asif Yildirim
RARamazan Gokhan Atis
Ramazan Gokhan Atis
TCTurhan Caskurlu
Turhan Caskurlu
Purpose: Three intravesical treatment agents were compared in an interstitial cystitis rat model: chondroitin sulfate, hyaluronic acid, and combined hyaluronic acid-chondroitin sulfate.Methods: Thirty-five female rats were divided into 5 groups: control (group I), isotonic (group II), chondroitin sulfate (group III), hyaluronic acid (group IV), and hyaluronic acid-chondroitin sulfate (group V). Chemical cystitis was induced in all experimental groups by intravesical instillation of 1 mL of hydrogen peroxide (H2O2) for 15 minutes via the transurethral route. The treatment was administered every other day for 3 sessions 2 days after inducing chemical cystitis. Groups II, III, IV, and V received 1 mL of 0.9% NaCl, 1 mL of 0.2% sodium chondroitin sulfate, 1 mL of low-molecular-weight hyaluronic acid, and 1 mL of 2% sodium chondroitin sulfate+1.6% sodium hyaluronic acid, respectively. On day 7, the animals were sacrificed and the bladders were removed for histopathological and immunohistochemical assessments.Results: Significant between-group differences were found in vascular congestion (P=0.006). The grade of submucosal edema in groups II and IV was significantly higher than in group I (P=0.006, P=0.006, respectively). In group I, the grade of granulation tissue was lower than the other 4 groups, but no significant difference was found between the remaining groups (P=0.016). Neutrophil cell infiltration was more intense in groups II and IV than in group I (P=0.006, P=0.006, respectively). Significant differences in the leukocyte and mast cell count were detected between groups II and IV (P<0.001, P<0.001, respectively). Abnormal zonula occludens-1 and uroplakin-III immunoreactivity in group II was higher than in groups I, III, or V (P=0.002, P=0.010, respectively). Interleukin-8 expression was lower in group V than in group II (P=0.001).Conclusion: A single treatment of chondroitin sulfate and combined hyaluronic acid-chondroitin sulfate treatment demonstrated efficacy by suppressing inflammation and achieving improvements in the urothelium.

20 November 2013 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
UOUral Oğuz
Ural Oğuz
MBMelih Balci
Melih Balci
GAGokhan Atis
Gokhan Atis
OBOmer Faruk Bozkurt
Omer Faruk Bozkurt
ATAltug Tuncel
Altug Tuncel
AUAli Unsal
Ali Unsal

1 January 2019 in Urology Research and Practice
Verified
Journal Article
Closed access
TTTurgay Turan
Turgay Turan
BGBerrin Güçlüer
Berrin Güçlüer
ÖEÖzgür Efiloğlu
Özgür Efiloğlu
FSFurkan Sendogan
Furkan Sendogan
RARamazan Gökhan Atış
Ramazan Gökhan Atış
AYAsıf Yıldırım
Asıf Yıldırım
Objective: To investigate the factors to predict Gleason score upgrading (GSU) of patients with prostate cancer who were evaluated by using the International Society for Urological Pathology (ISUP) 2014 Gleason grading system. Material and methods: Between January 2008 and December 2015, we retrospectively investigated patients who had undergone radical prostatectomy and followed up in the uro-oncology outpatient clinic. The pathologic specimens of the patients were evaluated based on the ISUP 2014 classification system. The patients were divided into two groups with or without upgraded Gleason scores. Factors that could be effective in predicting upgrading such as age, prostate-specific antigen (PSA), prostate volume, D’Amico risk classification, PSA density, cancer of the prostate risk assessment (CAPRA) scores, biopsy tumor percentage, body mass index, and clinical stage parameters were compared between both groups. Results: Of the 265 patients who could be evaluated and followed up regularly, Gleason score upgrades were observed in 110 (41.5%) patients. Advanced age (p=0.009), PSA >20 ng/mL (p=0.036), PSA density >0.35 (p=0.005), high CAPRA score (p=0.031), and high biopsy tumor percentage (p=0.009) were discovered to be correlated with Gleason score upgrade in univariate logistic regression analysis. Advanced age alone was a predictor for GSU in multivariate logistic regression analysis (p=0.002). Five-year biochemical recurrence-free survival rate was 86% in the non-GSU group and 55% in the GSU group (p<0.001). Conclusion: GSU risk should be taken into consideration in making therapeutic decisions for older patients with prostate cancer, and precautions should be taken against development of aggressive disease. Cite this article as: Turan T, Güçlüer B, Efiloğlu Ö, Şendoğan F, Atış RG, Çaşkurlu T, et al. The factors predicting upgrading of prostate cancer by using International Society for Urological Pathology (ISUP) 2014 Gleason grading system. Turk J Urol 2019; 45(Supp. 1): S36-S41.

1 January 2018 in Urology Research and Practice
Verified
Journal Article
Closed access
EPEyyüp Sabri Pelit
Eyyüp Sabri Pelit
BEBülent Erol
Bülent Erol
TZTülay Zenginkinet
Tülay Zenginkinet
TÇTurhan Çaşkurlu
Turhan Çaşkurlu
Testicular sex cord-stromal tumors constitute a small portion of all types of testicular tumors. Only 1% of these tumors are pure Sertoli cell tumors. Sertoli cell tumors have three identified subgroups: large-cell calcifying (LCCSCT), sclerosing Sertoli cell and general type. Up to 40% of LCCSCT are associated with the genetic syndromes like Carney complex, Peutz-Jeghers syndrome. These lesions are usually benign, only 17% of the cases show malignant behaviour. Herein, we report a case of unilateral LCCSCT in a 37 year-old man without any hormonal symptoms or inherited diseases which was succesfully treated with testis-sparing surgery. Cite this article as: Pelit ES, Erol B, Zenginkinet T, Çaşkurlu T. Testis-sparing surgery of unilateral testicular large cell calcifying sertoli cell tumor in a sporadic case. Turk J Urol 2018; 44: 370-2.

1 January 2020 in Urology Research and Practice
Verified
Journal Article
Closed access
ÖEÖzgür Efiloğlu
Özgür Efiloğlu
BBBanu İşbilen Başok
Banu İşbilen Başok
TTTurgay Turan
Turgay Turan
TTTuncay Toprak
Tuncay Toprak
BEBülent Erol
Bülent Erol
AYAsıf Yıldırım
Asıf Yıldırım
Objective: The current study aimed to examine the correlation between serum and urine transforming growth factor beta 1 (TGF-β1), matrix metallopeptidase 9 (MMP-9), tissue inhibitor of metalloproteinase 2 (TIMP-2), and nerve growth factor beta (NGF-β) levels and serum neutrophil-to-lymphocyte ratio (NLR) as well as the recurrence and progression risks of non-muscle invasive bladder cancer (NMIBC). Material and methods: The current study included 89 individuals: n=47, patients with primary NMIBC (patient group) and n=42, healthy controls (control group). The TGF-β1, MMP-9, TIMP-2, and NGF-β levels in the blood and urine samples were assessed using an enzyme-linked immunosorbent assay. Moreover, the serum NLR was evaluated. For the statistical analysis, a generalized linear model was used to compare the groups. In the analysis, gender and use of cigarettes were used as the secondary factors, and age was included as the covariate in the generalized linear model set for the intergroup evaluations. Meanwhile, a logistic regression model was utilized to evaluate the impact of the biomarkers on the risk of recurrence and progression. Results: The serum NLR was higher in the patient group than in the control group (p=0.033). The patients with disease recurrence had higher body mass index and MMP-9 levels, but the results were not statistically significant. Moreover, the patients with a high NLR had a high risk of disease progression (odds ratio [OR]=13.046, 95% confidence interval [CI]=1.057–161.18, p=0.045), whereas the patients with a high serum TGF-β1 level (OR=0.972, 95% CI=0.945–0.999, p=0.047) had a low risk of disease progression. Conclusion: High NLR and low TGF-β1 values were associated with an increased risk of disease progression in patients with NMIBC. However, no relationships were found between TGF-β1, MMP-9, TIMP-2, and NGF-β values and the recurrence of NMIBC. Cite this article as: Efiloğlu Ö, İşbilen Başok B, Turan T, Toprak T, Erol B, Çaşkurlu T, et al. Role of serum and urine transforming growth factor beta 1, matrix metallopeptidase 9, tissue inhibitor of metalloproteinase 2, and nerve growth factor beta levels and serum neutrophil-to-lymphocyte ratio in predicting recurrence and progression risks in patients with primary non-muscle invasive bladder cancer. Turk J Urol 2020; 46(3): 206-12.

1 December 2015 in International braz j urol
Verified
Journal Article
Open access
PDF file
OAOzgur Arikan
Ozgur Arikan
AYAsýf Yýldýrým
Asýf Yýldýrým
BÝBanu Ýsbilen
Banu Ýsbilen
CCCengiz CANAKCI
Cengiz CANAKCI
GAGokhan Atýs
Gokhan Atýs
TCTurhan Caskurlu
Turhan Caskurlu
Key words: HER2-neu-derived peptide (654-662) [Supplementary Concept]; Serum; Urinary Bladder Neoplasms